Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse

US11999676B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11999676-B2
Application numberUS-202016848462-A
CountryUS
Kind codeB2
Filing dateApr 14, 2020
Priority dateApr 21, 2016
Publication dateJun 4, 2024
Grant dateJun 4, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to methods of treatment of a disease or pathology of the central nervous system, an eating disorder, or substance use disorder, drug dependence/abuse and withdrawal therefrom comprising administering at least one N-phenylalkyl amphetamine derivative and pharmaceutical compositions comprising at least one N-phenylalkyl amphetamine derivative to an individual in need thereof.

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound of formula (I): wherein m is an integer in the range from 1 to 3; n is zero or an integer in the range from 1 to 5; R 1 and R 2 are independently an aryl group or a heteroaryl group, wherein R 1 is unsubstituted and R 2 is substituted with one or more substituents selected from the group consisting of mono-, di-, or tri-tritium; methyl; deuteromethyl (CD 3 ); tritiomethyl (CT 3 ); ethyl; propyl; isopropyl; C 4 -C 7 straight chain or branched alkyl; C 3 -C 6 cycloalkyl; C 4 -C 7 alkenyl (including cis and trans geometrical forms); alkylsulfonyl; alkylsulfinyl; phenylethyl; amino; cycloalkylamine, isopropylamino; N-methylamino; N,N-dimethylamino; carboxylate; methylcarboxylate; ethylcarboxylate; propylcarboxylate; isopropylcarboxylate; carboxaldehyde; acetoxy; propionyloxy; isopropionyloxy; cyano; aminomethyl; N-methylaminomethyl; N,N-dimethylaminomethyl; carboxamide; N-methylcarboxamide; N,N-dimethylcarboxamide; acetyl; propionyl; formyl; benzoyl; sulfate; phenyl; methylsulfate; hydroxyl; methoxy; difluoromethoxy; ethoxy; propoxy; isopropoxy; thiol; methylthio; ethylthio; propiothiol; chloro; bromo; iodo; trifluoromethyl; vinyl; allyl; propargyl; nitro; carbamoyl; ureido; azido; isocyanate; thioisocyanate; hydroxylamino; nitrile; a saturated or unsaturated hydrocarbon ring; a nitrogen containing heterocyclic or heteroaryl moiety; an oxygen containing heterocyclic or heteroaryl moiety; a sulfur containing heterocyclic or heteroaryl moiety; a selenium containing heterocyclic or heteroaryl moiety; a mixed heterocyclic or heteroaryl moiety containing at least two atoms selected from the group consisting of nitrogen, oxygen and sulfur; and ortho-, meta-, or para-substituted benzene; or wherein R 2 is unsubstituted and R 1 is substituted with one or more substituents selected from the group consisting of mono-, di-, or tri-tritium; methyl; deuteromethyl (CD 3 ); tritiomethyl (CT 3 ); ethyl; propyl; isopropyl; C 4 -C 7 straight chain or branched alkyl; C 3 -C 6 cycloalkyl; C 4 -C 7 alkenyl (including cis and trans geometrical forms); alkylsulfonyl; alkylsulfinyl; phenylethyl; amino; cycloalkylamine, isopropylamino; N-methylamino; N,N-dimethylamino; carboxylate; methylcarboxylate; ethylcarboxylate; propylcarboxylate; isopropylcarboxylate; carboxaldehyde; acetoxy; propionyloxy; isopropionyloxy; cyano; aminomethyl; N-methylaminomethyl; N,N-dimethylaminomethyl; carboxamide; N-methylcarboxamide; N,N-dimethylcarboxamide; acetyl; propionyl; formyl; benzoyl; sulfate; phenyl; methylsulfate; methoxy; difluoromethoxy; ethoxy; propoxy; isopropoxy; thiol; methylthio; ethylthio; propiothiol; fluoro; chloro; bromo; iodo; vinyl; allyl; propargyl; nitro; carbamoyl; ureido; azido; isocyanate; thioisocyanate; hydroxylamino; nitrile; a saturated or unsaturated hydrocarbon ring; a nitrogen containing heterocyclic or heteroaryl moiety; an oxygen containing heterocyclic or heteroaryl moiety; a sulfur containing heterocyclic or heteroaryl moiety; a selenium containing heterocyclic or heteroaryl moiety; a mixed heterocyclic or heteroaryl moiety containing at least two atoms selected from the group consisting of nitrogen, oxygen and sulfur; and ortho-, meta-, or para-substituted benzene; or wherein R 1 and R 2 are substituted with one or more substituents independently selected from the group consisting of mono-, di-, or tri-tritium; methyl; deuteromethyl (CD 3 ); tritiomethyl (CT 3 ); ethyl; propyl; isopropyl; C 4 -C 7 straight chain or branched alkyl; C 3 -C 6 cycloalkyl; C 4 -C 7 alkenyl (including cis and trans geometrical forms); alkylsulfonyl; alkylsulfinyl; phenylethyl; amino; cycloalkylamine, isopropylamino; N-methylamino; N,N-dimethylamino; carboxylate; methylcarboxylate; ethylcarboxylate; propylcarboxylate; isopropylcarboxylate; carboxaldehyde; acetoxy; propionyloxy; isopropionyloxy; cyano; aminomethyl; N-methylaminomethyl; N,N-dimethylaminomethyl; carboxamide; N-methylcarboxamide; N,N-dimethylcarboxamide; acetyl; propionyl; formyl; benzoyl; sulfate; phenyl; methylsulfate; hydroxyl; methoxy; difluoromethoxy; ethoxy; propoxy; isopropoxy; thiol; methylthio; ethylthio; propiothiol; fluoro; chloro; bromo; iodo; trifluoromethyl; vinyl; allyl; propargyl; nitro; carbamoyl; ureido; azido; isocyanate; thioisocyanate; hydroxylamino; nitrile; a saturated or unsaturated hydrocarbon ring; a nitrogen containing heterocyclic or heteroaryl moiety; an oxygen containing heterocyclic or heteroaryl moiety; a sulfur containing heterocyclic or heteroaryl moiety; a selenium containing heterocyclic or heteroaryl moiety; a mixed heterocyclic or heteroaryl moiety containing at least two atoms selected from the group consisting of nitrogen, oxygen and sulfur; and ortho-, meta-, or para-substituted benzene, wherein one or more of the benzyl; phenyl; saturated or unsaturated hydrocarbon ring; nitrogen containing heterocyclic or heteroaryl moiety; oxygen containing heterocyclic or heteroaryl moiety; sulfur containing heterocyclic or heteroaryl moiety; selenium containing heterocyclic or heteroaryl moiety; mixed heterocyclic or heteroaryl moiety containing at least two atoms selected from the group consisting of nitrogen, oxygen and sulfur; or ortho-, meta-, or para-substituted benzene substituent on R 1 or R 2 may be independently fused to R 1 or R 2 or linked to R 1 or R 2 ; R 3 is a methyl; ethyl; propyl; isopropyl; hydroxymethyl; 2-hydroxyethyl; 1-hydroxyethyl; methoxymethyl; 2-methoxyethyl; 1-methoxyethyl; aminomethyl; 2-aminoethyl; 1-aminoethyl; N-methylaminomethyl; 2-N-methylaminoethyl; 1-N-methylaminoethyl; N,N-dimethylaminomethyl; 2-N,N-dimethylaminoethyl; 1-N,N-dimethylaminoethyl; methyl, ethyl, propyl, or isopropyl substituted with one or more fluoro; or benzyl; R 4 is an ethyl, propyl, isopropyl, or carbonyl group; or a methyl, ethyl, propyl or isopropyl group substituted with a hydroxyaryl group; and R 5 is hydrogen or methyl; or an enantiomer; racemate; or pharmaceutically acceptable salt thereof; or wherein m is an integer in the range from 1 to 3; n is zero or an integer in the range from 1 to 5; R 1 and R 2 are independently an aryl group or a heteroaryl group, wherein R 2 is unsubstituted and R 1 is substituted with one or more substituents selected from the group consisting of mono-, di-, or tri-tritium; methyl; deuteromethyl (CD 3 ); tritiomethyl (CT 3 ); ethyl; propyl; isopropyl; C 4 -C 7 straight chain or branched alkyl; C 3 -C 6 cycloalkyl; C 4 -C 7 alkenyl (including cis and triflcycloalkylamine, isopropylamino; N-methylamino; N,N-dimethylamino; carboxylate; methylcarboxylate; ethylcarboxylate; propylcarboxylate; isopropylcarboxylate; carboxaldehyde; acetoxy; propionyloxy; isopropionyloxy; cyano; aminomethyl; N-methylaminomethyl; N,N-dimethylaminomethyl; carboxamide; N-methylcarboxamide; N,N-dimethylcarboxamide; acetyl; propionyl; formyl; benzoyl; sulfate; phenyl; methylsulfate; difluoromethoxy; ethoxy; propoxy; isopropoxy; thiol; methylthio; ethylthio; propiothiol; chloro; iodo; vinyl; allyl; propargyl; carbamoyl; ureido; azido; isocyanate; thioisocyanate; hydroxylamino; nitrile; a saturated or unsaturated hydrocarbon ring; a nitrogen containing heterocyclic or heteroaryl moiety; an oxygen containing heterocyclic or heteroaryl moiety; a sulfur containing heterocyclic or heteroaryl moiety; a selenium containing heterocyclic or heteroaryl moiety; a mixed heterocyclic or heteroaryl moiety containing at least two atoms selected from the group consisting of nitrogen, oxygen and sulfur; and ortho-, meta-, or para-substituted benzene; or wherein R 1 and R 2 are substituted with one or more substituents independently selected from the group consisting of mono-, di-, or tri-tritium; methyl; deuteromethyl (CD 3 ); tritiomethyl (CT 3 ); ethyl; propyl; i

Assignees

Inventors

Classifications

  • C07C211/53Primary

    having the nitrogen atom of at least one of the amino groups further bound to a hydrocarbon radical substituted by amino groups · CPC title

  • having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton · CPC title

  • Radicals substituted by nitrogen atoms, not forming part of a nitro radical · CPC title

  • having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom · CPC title

  • C07D215/12Primary

    with substituted hydrocarbon radicals attached to ring carbon atoms · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11999676B2 cover?
The present invention relates to methods of treatment of a disease or pathology of the central nervous system, an eating disorder, or substance use disorder, drug dependence/abuse and withdrawal therefrom comprising administering at least one N-phenylalkyl amphetamine derivative and pharmaceutical compositions comprising at least one N-phenylalkyl amphetamine derivative to an individual in need…
Who is the assignee on this patent?
Univ Kentucky Res Found
What technology area does this patent fall under?
Primary CPC classification C07C211/53. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).